X4 Pharmaceuticals XFOR
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 3.42 | 62 | -90.91 | -30 | -22.19 | 164 |
| 2025Q2 | 1.90 | 4 | -191.28 | -26 | -21.89 | 105 |
| 2025Q1 | 7.09 | 23 | 1.25 | 0 | 0.20 | 130 |
| 2024Q4 | 22.01 | 22 | -97.40 | -40 | -24.53 | 146 |
| 2024Q3 | 20.08 | 60 | -47.63 | -37 | -18.88 | 178 |
| 2024Q2 | 17.40 | 94 | 190.25 | 91 | 56.28 | 211 |
| 2024Q1 | 41.70 | 1 | -198.58 | -52 | -39.91 | 112 |
| 2023Q4 | 25.16 | 51 | -32.23 | -19 | -11.94 | 147 |
| 2023Q3 | 32.70 | 68 | -3.41 | -2 | -1.33 | 173 |
| 2023Q2 | 58.20 | 68 | -93.47 | -56 | -37.42 | 173 |
| 2023Q1 | 26.10 | 52 | -38.21 | -24 | -17.16 | 124 |
| 2022Q4 | 29.79 | 74 | -42.83 | -29 | -21.64 | 156 |
| 2022Q3 | 51.30 | 62 | -46.97 | -22 | -22.20 | 113 |
| 2022Q2 | 28.95 | 30 | -53.17 | -21 | -23.48 | 81 |
| 2022Q1 | 52.50 | 50 | -38.49 | -22 | -20.26 | 100 |
| 2021Q4 | 68.70 | 64 | -45.39 | -30 | -25.42 | 117 |
| 2021Q3 | 158.70 | 69 | -25.86 | -20 | -15.39 | 121 |
| 2021Q2 | 195.00 | 87 | -20.41 | -20 | -12.98 | 142 |
| 2021Q1 | 258.30 | 105 | -21.00 | -19 | -13.16 | 161 |
| 2020Q4 | 192.90 | 73 | -22.65 | -18 | -14.38 | 123 |